• banner image
  • banner image

Chairman's Profile

Being different and making a difference. That sums up the vision, philosophy, conviction and driving force behind Dr. Habil F Khorakiwala who revels in venturing down the road less travelled.

He founded Wockhardt in 1967. Today, the Wockhardt Group is India’s leading research-based, global healthcare enterprise with relevance in the fields of Pharmaceuticals, Biotechnology, Active Pharmaceutical Ingredients (APIs), and Super Speciality Hospitals.

Investor Information

Our investors, Wockhardt shareowners, are an important and valued constituent of the Wockhardt stakeholder universe.

While it is a matter of regulatory compliance, we also consider it as good governance and our duty and responsibility, to keep our investors informed and updated regularly about news, events and developments that impact our business and operations.

Investor Focus


FINANCIAL RESULTS FY23 Q3

FINANCIAL RESULTS FY23 Q2

FINANCIAL RESULTS FY23 Q1

About Us

Wockhardt is a leading, research-based, global enterprise with relevance in the fields of pharmaceuticals, biotechnology, and healthcare services.

Our multinational R&D and manufacturing facilities are spread across India, USA, UK and UAE, and our worldwide marketing presence includes over 30 countries across 6 continents. 

Our Products

  • product image

    Heparin Sodium Flushing Solution (previously known as Canusal

    Know More
  • product image

    Heparin Sodium 5000 I.U./ml (previously known as Multiparin

    Know More
  • product image

    Heparin Sodium Flushing Solution (previously known as Canusal

    Know More
  • product image

    Heparin Sodium Flushing Solution (previously known as Canusal

    Know More
  • product image

    Heparin Sodium Flushing Solution (previously known as Canusal

    Know More

  • product image

    Heparin Sodium Flushing Solution (previously known as Canusal

    Know More
  • product image

    Heparin Sodium 5000 I.U./ml (previously known as Multiparin

    Know More
  • product image

    Heparin Sodium Flushing Solution (previously known as Canusal

    Know More
  • product image

    Heparin Sodium Flushing Solution (previously known as Canusal

    Know More
  • product image

    Heparin Sodium Flushing Solution (previously known as Canusal

    Know More

Team Wockhardt

Team Wockhardt exhibits a global work culture and mindset in complete alignment with organisational goals and strives to excel, collectively as well as individually. Whole-heartedly adopting the corporate credo of Life Wins, Team Wockhardt has in place a strong leadership team with the bandwidth to ably lead the organisation into the future.

Life Wins

Global Reach

India Website India Website India Website rassia Chhatrapati Sambhajinagar Chhatrapati Sambhajinagar Chhatrapati Sambhajinagar Chhatrapati Sambhajinagar Switzerland Website London Website Ireland Website - USA East Website France Website

INVESTOR FOCUS

FINANCIAL RESULTS FY25 Q2

FINANCIAL RESULTS FY25 Q1

FINANCIAL RESULTS FY24 Q4

H1FY25 EBITDA at Rs. 239 crore; Growth by 112%

3 FOLD GROWTH IN WOCKHARDT’S EBITDA AT RS. 100 CRORE

WOCKHARDT’S EBITDA AT RS. 251 CRORE, YOY GROWTH ~ 74%

Voice of Wockhardians

My journey at Wockhardt began in April 2020, and it has been a transformative experience that has shaped my professional and personal growth.

LCS SRI VISHNU

AVP and Cluster Head, Sales & Marketing – Diabetes Business

At Wockhardt, I’ve found not only a fulfilling career but also a second family. The supportive and nurturing atmosphere cultivated by our Chairman has truly inspired me and my colleagues.

VIJAY MHATRE

Manager – Finance

Working at Wockhardt for over a decade, I’ve had a fulfilling experience, with diverse roles and projects that contributed to personal and professional growth.

JAGMOHAN SINGH RISHI

Head – Training, SFE & Digital Marketing, Sales Training

As the leader of the Drug Regulatory Affairs function for the Pharmaceuticals Business at our company, my primary responsibility is to guide the organization through the regulatory process to ensure successful translation of drug research and development into medicines for patients.

ZOHER SIHORWALA

Senior Vice President and Head – Drug Regulatory Affairs

My ten-year tenure with Wockhardt, a global pioneer in pharmaceuticals and biotechnology, has been a remarkable journey of growth and learning.

PRAVIN SAMBREY

Country Manager, International Marketing ROW


Beyond Pharmaceuticals

6 new drugs under development, accorded QIDP status by US FDA and in Phase III clinical stage, are being developed as novel antibiotics and are expected to significantly aid global efforts against Antimicrobial Resistance (AMR).

A chain of super-speciality hospitals offering world-class tertiary and quaternary healthcare services, Wockhardt Hospitals has built a reputation for quality, professionalism and positive outcomes.

Wockhardt Foundation implements several social initiatives to improve the quality of life of the underprivileged sections of society and manages to make a difference to over four million lives every year.
Wockhardt Global School, Aurangabad, is a not-for-profit initiative dedicated to developing a student community of lifelong learners that imbibes skills, knowledge and values required for global citizenship.

A chain of super-speciality hospitals offering world-class tertiary and quaternary healthcare services, Wockhardt Hospitals has built a reputation for quality, professionalism and positive outcomes.

Wockhardt Foundation implements several social initiatives to improve the quality of life of the underprivileged sections of society and manages to make a difference to over four million lives every year.
Wockhardt Global School, Aurangabad, is a not-for-profit initiative dedicated to developing a student community of lifelong learners that imbibes skills, knowledge and values required for global citizenship.